Julie Clark
Technik-/Wissenschafts-/F&E-Leiter bei OPTHEA LIMITED
Aktive Positionen von Julie Clark
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| OPTHEA LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2024 | - |
Karriereverlauf von Julie Clark
Ehemalige bekannte Positionen von Julie Clark
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Technik-/Wissenschafts-/F&E-Leiter | - | 22.10.2021 |
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.05.2011 | 01.10.2012 |
| IVERIC BIO, INC. | Corporate Officer/Principal | - | - |
Thrombogenics, Inc.
 Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The company is based in New York, NY. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Ausbildung von Julie Clark
| Wake Forest School of Medicine | Doctorate Degree |
| The Johns Hopkins University | Graduate Degree |
| Wake Forest University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 9 |
| Australien | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 2 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| OPTHEA LIMITED | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The company is based in New York, NY. | Commercial Services |
IVERIC bio, Inc.
 IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
- Börse
- Insiders
- Julie Clark
- Erfahrung
